PenRad forges alliance with GE

Article

Mammography information system developer PenRad Technologies of Plymouth, MN, has signed an exclusive distribution agreement with GE Medical Systems of Waukesha, WI, to sell its PenRad Mammography Information System (MIS). The software is Windows

Mammography information system developer PenRad Technologies of Plymouth, MN, has signed an exclusive distribution agreement with GE Medical Systems of Waukesha, WI, to sell its PenRad Mammography Information System (MIS). The software is Windows NT-based and provides medical auditing, tracking, and scheduling. The alliance gives PenRad access to GE’s extensive distribution networks, according to Gary Miars, executive vice president, and increases PenRad’s existing stable of OEM firms, which also includes Summit Medical Technologies of Arlington Heights, IL (SCAN 5/27/98).

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.